JUN 20, 2018 1:30 PM PDT

Regulation of Precision Medicine

Speaker

Abstract

Regulation of precision medicine is rapidly evolving.  The pre-existing regulatory framework did not contemplate many of the products and technologies which are becoming available with precision medicine.   FDA and other federal agencies have responded by attempting to develop a “flexible and adaptive” approach to regulation which simultaneously encourages innovation while still assuring that new precision medicine drugs and medical devices are safe and effective.
 
FDA has issued a series of non-binding “Guidance Documents” addressing different topics in precision medicine.   While non-binding, these guidance documents explain the Agency’s current thinking on specific issues and should be viewed as recommendations.

FDA in 2017 issued a Guidance Document relating to the use of “Real World Evidence” (RWE) to support regulatory decisions involving medical devices.   RWE represents a potentially faster, less expensive and more useful alternative to traditional randomized clinical trials (RCT’s) for generating data to support regulatory approvals of drugs and devices.  RWE consists of clinical evidence of a product's usage, benefits and risks obtained from an analysis of real-world data sources, such as patient EHR’s, insurance claims data and disease or device registries.  In 2017, FDA approved a new indication for a medical device based entirely on RWE.   

FDA has recently issued Guidance Documents and draft guidances covering many other aspects of precision medicine, including NGS–based tests, genetics variant databases and companion diagnostics.  Additionally, FDA and CMS have developed a parallel review process for devices aimed at allowing developers to concurrently obtain both marketing approval and eligibility for Medicare coverage. 

Many of FDA regulatory guidances have issued within the last 12 months.  It is likely that regulation of precision medicine will continue its evolution for the foreseeable future.


Show Resources
You May Also Like
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
AUG 16, 2022 11:00 AM PDT
AUG 16, 2022 11:00 AM PDT
Date: August 16, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing pers...
JUN 28, 2022 7:00 AM PDT
JUN 28, 2022 7:00 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
AUG 24, 2022 7:00 AM PDT
AUG 24, 2022 7:00 AM PDT
Date: August 24, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) Light field microscopy was first introduced in 2006, and allows users to capture the 4D light field within the microsco...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
JUN 20, 2018 1:30 PM PDT

Regulation of Precision Medicine



Show Resources
Loading Comments...
Show Resources